Literature DB >> 1751529

Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo.

A Chonn1, S C Semple, P R Cullis.   

Abstract

In order to facilitate the isolation of liposomes from blood components, we have developed a simple and rapid procedure combining chromatographic and centrifugal methods. This 'spin column' procedure was used to isolate liposomes from incubation mixtures with human serum or from the blood of CD1 mice after intravenous administration of liposomes. An advantage of this procedure is that processing times are fast (typically minutes) such that the isolation procedure can be done in the absence of chelators or other coagulation inhibitors which may affect protein/liposome interactions. Furthermore, several samples can be analyzed together and small sample volumes can be processed. In addition, we show that this spin column procedure can be employed to isolate large unilamellar vesicles averaging 100 nm in diameter from lipoproteins and plasma proteins. The applicability of this spin column procedure in studying protein/liposome interactions is demonstrated by quantitating the amount of human complement component C3 bound per liposome using a C3 competitive ELISA assay after incubation with human serum. The proteins associated with the recovered liposomes were further analyzed by conventional SDS-polyacrylamide gel electrophoresis. We show that egg phosphatidylcholine/cholesterol (55:45, mol/mol) or egg phosphatidylcholine/cholesterol/dioleoylphosphatidylserine (35:45:20, mol/mol) liposomes isolated from the circulation of CD1 mice within minutes of administration have distinct, complex profiles of associated proteins. By isolating circulating large unilamellar liposomes using the spin column method and characterizing the proteins associated with their membranes, this protein fingerprinting approach will expedite identifying protein interactions which affect liposome stability and clearance in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751529     DOI: 10.1016/0005-2736(91)90167-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Nutrient uptake by protocells: a liposome model system.

Authors:  P A Monnard; D W Deamer
Journal:  Orig Life Evol Biosph       Date:  2001 Feb-Apr       Impact factor: 1.950

2.  Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Amir Maghsoudi; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

3.  Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes.

Authors:  Shihong Li; Beth Goins; Brian A Hrycushko; William T Phillips; Ande Bao
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

Review 4.  Challenges in development of targeted liposomal therapeutics.

Authors:  Rupa R Sawant; Vladimir P Torchilin
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

5.  Pharmacokinetics of paclitaxel-containing liposomes in rats.

Authors:  Gerald J Fetterly; Robert M Straubinger
Journal:  AAPS PharmSci       Date:  2003-11-21

6.  Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin.

Authors:  Kunihiko Iwamoto; Tomohiro Hayakawa; Motohide Murate; Asami Makino; Kazuki Ito; Tetsuro Fujisawa; Toshihide Kobayashi
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

7.  Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).

Authors:  Stephan Holzschuh; Kathrin Kaeß; Alfred Fahr; Christiane Decker
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

Review 8.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

Review 9.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

Review 10.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.